These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30381896)

  • 21. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.
    Giebel S; Boratyn-Nowicka A; Karabon L; Jedynak A; Pamula-Pilat J; Tecza K; Kula D; Kowal M; Frydecka I; Grzybowska E
    Hum Immunol; 2014 Jun; 75(6):508-13. PubMed ID: 24755350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.
    Keating SE; Ní Chorcora C; Dring MM; Stallings RL; O'Meara A; Gardiner CM
    Tissue Antigens; 2015 Sep; 86(3):172-7. PubMed ID: 26202659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C.
    Moradi S; Stankovic S; O'Connor GM; Pymm P; MacLachlan BJ; Faoro C; Retière C; Sullivan LC; Saunders PM; Widjaja J; Cox-Livingstone S; Rossjohn J; Brooks AG; Vivian JP
    Nat Commun; 2021 Apr; 12(1):2173. PubMed ID: 33846289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Killer cell immunoglobulin-like receptor (KIR) genes in systemic sclerosis.
    Salim PH; Jobim M; Bredemeier M; Chies JA; Schlottfeldt J; Brenol JC; Jobim LF; Xavier RM
    Clin Exp Immunol; 2010 Jun; 160(3):325-30. PubMed ID: 20082621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.
    Moesta AK; Norman PJ; Yawata M; Yawata N; Gleimer M; Parham P
    J Immunol; 2008 Mar; 180(6):3969-79. PubMed ID: 18322206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition.
    Schönberg K; Sribar M; Enczmann J; Fischer JC; Uhrberg M
    Blood; 2011 Jan; 117(1):98-107. PubMed ID: 20935255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.
    Foley B; Cooley S; Verneris MR; Pitt M; Curtsinger J; Luo X; Lopez-Vergès S; Lanier LL; Weisdorf D; Miller JS
    Blood; 2012 Mar; 119(11):2665-74. PubMed ID: 22180440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
    Guo KY; Mei JZ; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Killer Cell Immunoglobulin-like Receptors and Their HLA Ligands are Related with the Immunopathology of Chagas Disease.
    Ayo CM; Reis PG; Dalalio MM; Visentainer JE; Oliveira Cde F; de Araújo SM; de Oliveira Marques DS; Sell AM
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003753. PubMed ID: 25978047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human NK cells licensed by killer Ig receptor genes have an altered cytokine program that modifies CD4+ T cell function.
    Lin L; Ma C; Wei B; Aziz N; Rajalingam R; Yusung S; Erlich HA; Trachtenberg EA; Targan SR; McGovern DP; Heath JR; Braun J
    J Immunol; 2014 Jul; 193(2):940-9. PubMed ID: 24935928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide antagonism as a mechanism for NK cell activation.
    Fadda L; Borhis G; Ahmed P; Cheent K; Pageon SV; Cazaly A; Stathopoulos S; Middleton D; Mulder A; Claas FH; Elliott T; Davis DM; Purbhoo MA; Khakoo SI
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10160-5. PubMed ID: 20439706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer Activity.
    Blunt MD; Vallejo Pulido A; Fisher JG; Graham LV; Doyle ADP; Fulton R; Carter MJ; Polak M; Johnson PWM; Cragg MS; Forconi F; Khakoo SI
    J Immunol; 2022 Jul; 209(2):379-390. PubMed ID: 35768150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural killer cell activity and frequency of killer cell immunoglobulin-like receptors in children with different forms of juvenile idiopathic arthritis.
    Zhou J; Tang X; Ding Y; An Y; Zhao X
    Pediatr Allergy Immunol; 2013 Nov; 24(7):691-6. PubMed ID: 24112428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer.
    Cornillet M; Jansson H; Schaffer M; Hertwig L; Berglin L; Zimmer CL; Johansson H; Ellis E; Isaksson B; Gonzalez-Galarza FF; Middleton D; Malmberg KJ; Sparrelid E; Björkström NK
    Gastroenterology; 2019 Oct; 157(4):1067-1080.e9. PubMed ID: 31229495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of KIR2DL3 and KIR2DS2 natural killer receptors in exercise.
    Shleptsova VA; Grebenyuk ES; Khaustova SA; Obraztsova NP; Shkurnikov MY; Sakharov DA; Tonevitsky EA
    Bull Exp Biol Med; 2010 Nov; 149(6):755-8. PubMed ID: 21165439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KIR2DL2 and KIR2DS2 as genetic markers to the methotrexate response in rheumatoid arthritis patients.
    Velarde-de la Cruz EE; Sánchez-Hernández PE; Muñoz-Valle JF; Palafox-Sánchez CA; Ramírez-de Los Santos S; Graciano-Machuca O; García-Iglesias T; Montoya-Buelna M; Ramírez-Dueñas MG
    Immunopharmacol Immunotoxicol; 2016 Aug; 38(4):303-9. PubMed ID: 27251940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection.
    Charoudeh HN; Terszowski G; Czaja K; Gonzalez A; Schmitter K; Stern M
    Eur J Immunol; 2013 Feb; 43(2):480-7. PubMed ID: 23161492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KIR downregulation by IL-12/15/18 unleashes human NK cells from KIR/HLA-I inhibition and enhances killing of tumor cells.
    Ewen EM; Pahl JHW; Miller M; Watzl C; Cerwenka A
    Eur J Immunol; 2018 Feb; 48(2):355-365. PubMed ID: 29105756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
    Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.
    Winter CC; Gumperz JE; Parham P; Long EO; Wagtmann N
    J Immunol; 1998 Jul; 161(2):571-7. PubMed ID: 9670929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.